Skin-to-Skin Contact Diminishes Pain From Hepatitis B Vaccine Injection in Healthy Full-Term Neonates
Document Type
Article
Publication Date
7-1-2013
Publication Title
Neonatal Network
Abstract
Purpose: This study was conducted to test the hypothesis that skin-to-skin contact (SSC) would reduce hepatitis B vaccine injection pain in full-term neonates. Design: Randomized controlled trial (RCT ). Sample: Thirty-six mother-;neonate dyads were randomly assigned to SSC or control groups. Main Outcomes: Cry time (CT ), behavioral state (BSt), and heart rate (HR ) were measured throughout the 16-minute protocol. HR and BSt were measured every 30 seconds; CT was recorded continuously. Results: SSC neonates cried less compared with controls (23 vs 32 seconds during injection; 16 vs 72 seconds during recovery), reached calmer BSts sooner (M = 2.8 vs M = 6.5 time points), and trended toward more rapid HR decrease. SSC as described was safe and effective and merits further testing.
DOI
10.1891/0730-0832.32.4.274
Recommended Citation
Kostandy, R. R., Anderson, G., & Good, M. (2013). Skin-to-Skin Contact Diminishes Pain From Hepatitis B Vaccine Injection in Healthy Full-Term Neonates. Neonatal Network, 32(4), 274-280. doi: 10.1891/0730-0832.32.4.274
Volume
32
Issue
4